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Background
Cardiac involvement with progressive myocardial fibrosis
leading to dilated cardiomyopathy is a major cause of
death in muscular dystrophy patients. Extracellular volume
fraction (ECV) measurement based on T1-mapping pre-
and post-contrast promises the detection of early “diffuse”
myocardial fibrosis that cannot be depicted by conven-
tional contrast-imaging based on late gadolinium enhance-
ment (LGE). With this study, we evaluated the presence of
diffuse myocardial fibrosis in regions of “normal” (LGE-
negative) and “diseased” (LGE-positive) appearing myocar-
dium as well as its relation to the extent of left ventricular
(LV) dysfunction and the occurrence of arrhythmias in
Becker muscular dystrophy (BMD) patients.
Methods
Twenty-seven BMD patients (35 ± 12 yrs) and 28
matched healthy CONTROLS (33 ± 8 yrs) underwent
cardiovascular magnetic resonance (CMR) studies
including ECV measurement and LGE-imaging. Ambu-
latory monitoring of arrhythmic events was performed
by means of an external event loop recorder.
Results
Twenty BMD patients (74%) demonstrated cardiac
involvement as detected by typical inferolateral presence
of LGE. Twelve patients (44%) had an impaired LV ejec-
tion fraction - all being LGE-positive. Global myocardial
ECV was significantly higher in the BMD group (29 ±
6%) compared to the CONTROL group (25 ± 3%, p =
0.005). Patients with cardiac involvement demonstrated
higher global ECV (31 ± 6%) as well as significantly
increased regional ECV not only in LGE-positive seg-
ments (34 ± 6%), but also in LGE-negative segments
(28 ± 6%) compared to BMD patients without cardiac
involvement and to CONTROLS, respectively (24 ± 3%
and 25 ± 3%, p = 0.01). Global ECV in patients with car-
diac involvement substantially correlated to LV ejection
fraction (r = -0.629, p = 0.003) and to the number of
LGE-positive segments (r = 0.783, p < 0.001). On univari-
able analysis, global ECV - but not the categorical pre-
sence of LGE per se - was significantly associated with
arrhythmic events (OR 1.97, CI 32.22-1.21, p = 0.032).
Conclusions
ECV measurement by CMR is a useful tool in assessing
the total extent of myocardial fibrosis as well as in
depicting subtle diffuse fibrosis in areas of normal
appearing myocardium on LGE-images. Thus, myocar-
dial ECV is a potential additional quantitative tool for
accurate detection of cardiac involvement and risk stra-
tification in muscular dystrophy patients.
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